Optinose, Inc. (OPTN), a pharmaceutical company, announced on Thursday that it will implement a reverse stock split at a ratio of 1-for-15, effective at 5:00 p.m. ET on December 30. This move aims to meet Nasdaq's requirement of maintaining a minimum closing bid price of $1.00 for continued listing.
The material has been provided by InstaForex Company - www.instaforex.com
The material has been provided by InstaForex Company - www.instaforex.com